Welcome to LookChem.com Sign In|Join Free

CAS

  • or

116133-09-6

Post Buying Request

116133-09-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

116133-09-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 116133-09-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,1,3 and 3 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 116133-09:
(8*1)+(7*1)+(6*6)+(5*1)+(4*3)+(3*3)+(2*0)+(1*9)=86
86 % 10 = 6
So 116133-09-6 is a valid CAS Registry Number.

116133-09-6Downstream Products

116133-09-6Relevant articles and documents

Di- and tri-substituted s-triazine derivatives: Synthesis, characterization, anticancer activity in human breast-cancer cell lines, and developmental toxicity in zebrafish embryos

El-Faham, Ayman,Farooq, Muhammad,Almarhoon, Zainab,Alhameed, Rakia Abd,Wadaan, Mohammad A.M.,de la Torre, Beatriz G.,Albericio, Fernando

, (2020)

Here we report on a small library based on a 4-aminobenzonitile-s-triazine moiety. We used a straightforward orthogonal synthetic pathway to prepare di- and tri-substituted s-triazine derivatives, whose basic structure was modified. The newly synthesized compounds were fully characterized by 1H NMR, 13C NMR and elemental analysis. They showed strong anticancer activity against two human breast cancer cell lines (MIDA-MB-231 and MCF-7), with IC50 values less than 1 μM. These s-triazine compounds were generally more selective towards hormone receptor-positive breast cancer cell line MCF-7 than the triple negative MDA-MB-231 cell line. Zebrafish embryos were used to test the developmental toxicity of the target compounds in vivo. The phenotype of embryos treated with the derivatives resembled that of those treated with estrogen disruptors. This observation strongly supports the notion that that these compounds induce their anticancer activity in human breast cancer cells via targeting the estrogen and progesterone receptors.

Indoloxytriazines as binding molecules for the JAK2 JH2 pseudokinase domain and its V617F variant

Newton, Ana S.,Liosi, Maria-Elena,Henry, Sean P.,Deiana, Luca,Faver, John C.,Krimmer, Stefan G.,Puleo, David E.,Schlessinger, Joseph,Jorgensen, William L.

supporting information, (2021/07/20)

Small molecules that selectively bind to the pseudokinase JH2 domain over the JH1 kinase domain of JAK2 kinase are sought. Virtual screening led to the purchase of 17 compounds among which 9 were found to bind to V617F JAK2 JH2 with affinities of 40 – 300

Optimization of the pharmacokinetic properties of potent anti-trypanosomal triazine derivatives

Salado, Irene G.,Baán, Adrienn,Verdeyen, Tomas,Matheeussen, An,Caljon, Guy,Van der Veken, Pieter,Kiekens, Filip,Maes, Louis,Augustyns, Koen

, p. 18 - 26 (2018/04/02)

Human African trypanosomiasis is causing thousands of deaths every year in the rural areas of sub-saharan Africa. There is a high unmet medical need since the approved drugs are poorly efficacious, show considerable toxicity and are not easy to administer

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 116133-09-6